{"id":"W4394576831","doi":"10.1080/03007995.2024.2326585","title":"Real-world clinical outcomes and healthcare costs in patients with Crohn’s disease treated with vedolizumab versus ustekinumab in the United States","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Vedolizumab; Ustekinumab; Medicine; Crohn's disease; Health care; Disease; Internal medicine; Intensive care medicine; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00209685,0.0002430265,0.0006127873,0.0008171273,0.0002328317,0.00094927,0.0003531158,0.0004531898,0.0007524004],"category_scores_gemma":[0.008404199,0.0002116996,0.0008902089,0.00128964,0.0003094519,0.0008856956,0.0006413192,0.0006222097,0.00008142796],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009660375,"about_ca_system_score_gemma":0.0004053393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004416713,"about_ca_topic_score_gemma":0.0047705,"domain_scores_codex":[0.997724,0.001078447,0.0003547562,0.0003693993,0.0002875362,0.0001857142],"domain_scores_gemma":[0.9943873,0.001118186,0.003808073,0.000133235,0.0002405151,0.0003127005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001769745,0.0001471698,0.991931,0.00006912369,0.0007758382,0.00006572314,0.00007754106,0.0009385647,0.00008606866,0.0001125625,0.0003638275,0.003662868],"study_design_scores_gemma":[0.0001960235,0.0008871782,0.9931224,0.00006768037,0.0003542338,0.000311306,0.0003724064,0.003756496,0.0001110712,0.000192457,0.0006079522,0.00002077869],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979402,0.0007869861,0.00009235203,0.0001164351,0.000008485216,0.00001108123,0.0008515108,0.000001693275,0.0001912615],"genre_scores_gemma":[0.9984962,0.0002224429,0.0001215708,0.00006330529,0.00001478797,0.00001754033,0.001029911,0.000001085052,0.00003323196],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004416713,"threshold_uncertainty_score":0.01108932,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0629340616122963,"score_gpt":0.4319096553517118,"score_spread":0.3689755937394155,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}